Your browser doesn't support javascript.
loading
Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform.
Chaudhury, Sidhartha; Hutter, Jack; Bolton, Jessica S; Hakre, Shilpa; Mose, Evelyn; Wooten, Amy; O'Connell, William; Hudak, Joseph; Krebs, Shelly J; Darden, Janice M; Regules, Jason A; Murray, Clinton K; Modjarrad, Kayvon; Scott, Paul; Peel, Sheila; Bergmann-Leitner, Elke S.
Afiliação
  • Chaudhury S; Center Enabling Capabilities, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Hutter J; Clinical Trials Center, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Bolton JS; Immunology Core, Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Hakre S; Henry M. Jackson Foundation for The Advancement of Military Medicine, Bethesda, MD, United States of America.
  • Mose E; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Wooten A; Brian D. Allgood Army Community Hospital, Camp Humphreys, Pyeongtaek, South Korea.
  • O'Connell W; Brian D. Allgood Army Community Hospital, Camp Humphreys, Pyeongtaek, South Korea.
  • Hudak J; Brian D. Allgood Army Community Hospital, Camp Humphreys, Pyeongtaek, South Korea.
  • Krebs SJ; Brian D. Allgood Army Community Hospital, Camp Humphreys, Pyeongtaek, South Korea.
  • Darden JM; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Regules JA; Henry M. Jackson Foundation for The Advancement of Military Medicine, Bethesda, MD, United States of America.
  • Murray CK; Immunology Core, Malaria Biologics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Modjarrad K; United States Forces Korea Surgeon, Camp Humphreys, South Korea.
  • Scott P; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Peel S; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Bergmann-Leitner ES; Diagnostics and Countermeasures Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
PLoS One ; 16(6): e0252628, 2021.
Article em En | MEDLINE | ID: mdl-34081747
Serological assessment of SARS-CoV-2 specific responses are an essential tool for determining the prevalence of past SARS-CoV-2 infections in the population especially when testing occurs after symptoms have developed and limited contact tracing is in place. The goal of our study was to test a new 10-plex electro-chemiluminescence-based assay to measure IgM and IgG responses to the spike proteins from multiple human coronaviruses including SARS-CoV-2, assess the epitope specificity of the SARS-CoV-2 antibody response against full-length spike protein, receptor-binding domain and N-terminal domain of the spike protein, and the nucleocapsid protein. We carried out the assay on samples collected from three sample groups: subjects diagnosed with COVID-19 from the U.S. Army hospital at Camp Humphreys in Pyeongtaek, South Korea; healthcare administrators from the same hospital but with no reported diagnosis of COVID-19; and pre-pandemic samples. We found that the new CoV-specific multiplex assay was highly sensitive allowing plasma samples to be diluted 1:30,000 with a robust signal. The reactivity of IgG responses to SARS-CoV-2 nucleocapsid protein and IgM responses to SARS-CoV-2 spike protein could distinguish COVID-19 samples from non-COVID-19 and pre-pandemic samples. The data from the three sample groups also revealed a unique pattern of cross-reactivity between SARS-CoV-2 and SARS-CoV-1, MERS-CoV, and seasonal coronaviruses HKU1 and OC43. Our findings show that the CoV-2 IgM response is highly specific while the CoV-2 IgG response is more cross-reactive across a range of human CoVs and also showed that IgM and IgG responses show distinct patterns of epitope specificity. In summary, this multiplex assay was able to distinguish samples by COVID-19 status and characterize distinct trends in terms of cross-reactivity and fine-specificity in antibody responses, underscoring its potential value in diagnostic or serosurveillance efforts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos